Another digital therapeutics app for treating insomnia has been approved by the South Korean Ministry of Food and Drug Safety.
The mobile app called WELT-I by Welt Co. is the second insomnia DTx to be approved in the country.
WHAT IT DOES
WELT-I uses cognitive behavioural therapy (CBT), which is the first-line treatment for insomnia, to address the underlying causes of chronic insomnia.
It is a...
A clinical trial in New Zealand found a virtual reality app-based cognitive behaviour therapy programme reduced the symptoms of common phobias.
FINDINGS
Conducted between May and December last year, the randomised, controlled trial recruited a total of 129 adult participants with fears of flying, heights, needles, spiders and dogs. It was led by Dr Cameron Lacey, associate professor from the...
Seed funding of €2 million has been raised by medtech startup Inflow for its novel science-based app for ADHD patients, according to EU Startups.
Among the investors are Hoxton Ventures and Route 66 Ventures, along with angel investor Quit Genius.
WHY IT MATTERS
With the launch of their innovative app, the London-based founders Levi Epstein and Seb Isaacs want to enable ADHD patients to actively...
Weight management startup Noom is now diving into the behavioral health space with the launch of Noom Mood. The new platform was designed to help individuals manage stress and anxious thoughts, as well as boost health habits.
Users will be able to tap into daily 10-minute lessons based on Cognitive Behavioral Therapy (CBT), Dialectical Behavioral Therapy (DBT) and Acceptance Commitment Theory (...
With an eye on the rising need for mental health services, healthtech company Limbic has launched a suite of new products.
Limbic Self-Care, Limbic Care and Limbic Prevent are designed to help clinicians by using conversational AI to provide end-to-end support at different points of patients’ treatment pathways.
Clinicians can start with Limbic Self-Care which provides instant CBT support to...
Guided internet-based cognitive behavioral therapy (iCBT) outperformed both unguided iCBT and treatment as usual for treating depression, according to a new meta-analysis of 39 studies published in JAMA yesterday.
Additionally, researchers found that unguided iCBT also reduced depression symptom compared to treatment as usual and waiting list.
The difference between guided and unguided iCBT comes...
A recent mathematical simulation model found that, compared to other insomnia interventions like group cognitive behavioral therapy or pharmacotherapy, digital CBT delivered via Big Health's Sleepio was more cost-effective due to lower expenditures.
The research was funded by Big Health, and conducted by researchers from Johns Hopkins, the University of California, San Francisco, and the digital...
Bold Health, a London-based company developing digital therapeutics for gastrointestinal conditions, is backing a new University of Pennsylvania-led study that will directly compare the company's cognitive behavior therapy (CBT) app for irritable bowel syndrome (IBS) to Headspace's consumer mindfulness and meditation app.
According to a clinicaltrials.gov listing spotted by Exits & Outcomes,...
Editor's note: This story has been updated with quotes and additional information from Mahana's CEO and cofounder.
The FDA has granted a De Novo clearance to San Francisco-based Mahana Therapeutics' Parallel, a prescription digital therapeutic for patients with irritable bowel syndrome (IBS) that delivers cognitive behavioral therapy (CBT).
The agency made its decision on November 25, according...
New data suggest that an Internet-delivered cognitive behavioral therapy (ICBT) intervention not only remained effective after 12 months among adolescents with obsessive-compulsive disorder, but seemed to have an even greater impact on their symptoms with time.
Published last week in npj digital medicine, the analysis updated a previously reported three-month study with one-year data from the...